Nørresundby Fodklinik ApS, statsautoriseret fodterapeut

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  10.6% 2.9% 2.2% 2.6% 4.1%  
Credit score (0-100)  24 58 65 61 48  
Credit rating  BB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  1,197 0 0 0 0  
Gross profit  622 582 797 971 1,181  
EBITDA  395 324 365 348 128  
EBIT  260 223 241 124 48.7  
Pre-tax profit (PTP)  246.3 213.7 236.9 119.9 11.7  
Net earnings  192.1 164.5 184.3 93.0 8.0  
Pre-tax profit without non-rec. items  246 214 237 120 11.7  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  403 302 371 670 710  
Shareholders equity total  258 422 606 699 707  
Interest-bearing liabilities  202 0.0 0.0 450 460  
Balance sheet total (assets)  607 659 753 1,231 1,224  

Net Debt  201 -197 -238 123 271  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  1,197 0 0 0 0  
Net sales growth  125.2% -100.0% 0.0% 0.0% 0.0%  
Gross profit  622 582 797 971 1,181  
Gross profit growth  109.1% -6.4% 36.9% 21.9% 21.6%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 -1,053.5  
Balance sheet total (assets)  607 659 753 1,231 1,224  
Balance sheet change%  40.6% 8.5% 14.3% 63.5% -0.6%  
Added value  394.6 323.8 364.6 248.1 1,181.1  
Added value %  33.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -16 -201 -55 76 -39  

Net sales trend  1.0 -1.0 0.0 0.0 0.0  
EBIT trend  2.0 3.0 4.0 5.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  33.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  21.8% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  41.9% 38.3% 30.2% 12.8% 4.1%  
Net Earnings %  16.1% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  27.3% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  20.6% 0.0% 0.0% 0.0% 0.0%  
ROA %  50.1% 35.2% 34.1% 12.5% 4.0%  
ROI %  68.7% 50.6% 46.8% 14.2% 4.2%  
ROE %  118.9% 48.4% 35.8% 14.2% 1.1%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  42.4% 64.0% 80.5% 56.8% 57.8%  
Relative indebtedness %  29.2% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  29.1% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  50.8% -60.9% -65.3% 35.3% 212.6%  
Gearing %  78.5% 0.0% 0.0% 64.4% 65.0%  
Net interest  0 0 0 0 0  
Financing costs %  6.5% 9.3% 0.0% 2.0% 8.1%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  1.0 1.2 2.3 1.0 0.8  
Current Ratio  1.2 1.5 2.6 1.1 1.0  
Cash and cash equivalent  1.7 197.2 237.9 327.5 188.3  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  17.1% 0.0% 0.0% 0.0% 0.0%  
Net working capital  37.8 119.9 235.3 29.0 -2.7  
Net working capital %  3.2% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0